Loading...

Emerging Glioma Therapy And Lung Cancer Expansion Will Transform Long Term Oncology Franchise

Published
05 Dec 25
Views
20
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
216.4%
7D
-0.8%

Author's Valuation

US$10.2517.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value